Rob Koremans, CEO of Italian pharmaceutical company Recordati, weighs in on the company's purchase of Sanofi's rare immune ...

Sanofi, a leading global healthcare company, has received the “Corporate Social Impact Award 2024 – Gold level” for the fifth ...

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

Sanofi, and Molecular Partners AG. According to TipRanks, Vosser has an average return of 5.0% and a 49.18% success rate on recommended stocks. Merck KGaA has an analyst consensus of Strong Buy, with ...

US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria: Paris Monday, November 18, 2024, 11:00 Hrs [IST] The US Food and Drug Admin ...

Nifty moved in a tight range of 82 points, and ended slightly below the psychologically crucial level of 15,700. NEW DELHI: ...

Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

The White House appointment of the anti-vax conspiracy theorist is devastating ASX healthcare and biotech shares as he ...

Over 2 decades ago, the aldosterone antagonist eplerenone proved beneficial after MI complicated by left ventricular ...

This report explores the benefits and challenges of NHS-industry partnerships aiming to catalyse improvements in the health ...

Trump announced Thursday he'll nominate Robert F. Kennedy Jr. to be secretary of the Health and Human Services Department, ...

An Osaka Metropolitan University-led team evaluated the effects of SGLT2 inhibitors in protecting the kidneys, showing that ...